Charisse R. Lillie - Dec 31, 2024 Form 4 Insider Report for EXELON CORP (EXC)

Role: Director
Signature: David T. Skinner, attorney-in-fact for Charisse R Lillie
Stock symbol: EXC
Transactions as of: Dec 31, 2024
Transactions value $: $41,258
Form type: 4
Date filed: 1/3/2025, 10:36 AM
Previous filing: Oct 2, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EXC	Common stock- deferred stock units	Award	$41.3K	+1.12K	+17.61%	$36.87	7.47K	Dec 31, 2024	By Exelon Corp. Directors Deferred Stock Unit Plan	F1
holding	EXC	Common Stock						7.25K	Dec 31, 2024	Direct

Showing 1 to 2 of 2 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	EXC	Deferred phantom share equivalents						3.7K	Dec 31, 2024	Common Stock	3.7K		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Balance includes 65 additional shares acquired through automatic dividend reinvestment.
F2	Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.
F3	Balance includes 36 additional phantom share equivalents that were accrued to the account by the plan administrator on the ex-dividend date.